Community Central Line Infection Prevention Trial

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Infection
Interventions
DEVICE

70% Isopropyl alcohol embedded caps

Protective cap on central lines

OTHER

Usual Care

"This involves the Best Practice Central Line Maintenance Care Bundle which includes;~1. Daily assessment whether central line is needed~2. Central line Site Care~3. Central line Hub/Cap/Tubing Care"

Trial Locations (16)

10467

Children's Hospital of Montefiore, The Bronx

19603

Nemours Alfred Dupont Hospital for Children, Wilmington

21287

Johns Hopkins Children's Center, Baltimore

Johns Hopkins University, Baltimore

29425

Medical University of South Carolina Children's Hospital, Charleston

32608

University of Florida Children's Hospital, Gainesville

35233

Children's Hospital of Alabama, Birmingham

40202

Norton Children's Hospital, Louisville

43205

Nationwide Children's Hospital, Columbus

44308

Akron Children's Hospital, Akron

48201

Children's Hospital of Michigan, Detroit

63110

St Louis Children's Hospital, St Louis

72202

Arkansas Children's Hospital, Little Rock

77030

Texas Children's Hospital, Houston

80045

Children's Hospital of Colorado, Aurora

97239

Doernbecher Children's Hospital, Portland

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Johns Hopkins University

OTHER

NCT02351258 - Community Central Line Infection Prevention Trial | Biotech Hunter | Biotech Hunter